The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 03, 2020

Filed:

Aug. 11, 2019
Applicant:

Definiens Ag, Munich, DE;

Inventors:

Nathalie Harder, Munich, DE;

Maria Athelogou, Munich, DE;

Assignee:

Definiens AG, Munich, DE;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
G06T 7/00 (2017.01); G06N 7/00 (2006.01); G06K 9/46 (2006.01); G06K 9/52 (2006.01); G06K 9/62 (2006.01); G06K 9/66 (2006.01);
U.S. Cl.
CPC ...
G06N 7/005 (2013.01); G06K 9/4652 (2013.01); G06K 9/52 (2013.01); G06K 9/6267 (2013.01); G06K 9/66 (2013.01); G06T 7/0012 (2013.01); G06K 2009/4666 (2013.01); G06T 2207/30004 (2013.01); G06T 2207/30024 (2013.01); G06T 2207/30081 (2013.01); G06T 2207/30242 (2013.01);
Abstract

A system predicts the recurrence of cancer. A first slice of a prostate tissue sample is stained so that luminal epithelial cells and basal epithelial cells are stained different colors. A first digital image is taken of the first slice. The second slice of the sample is stained so that M1 type macrophages and M2 type macrophages are differentially stained. A second digital image is taken of the second slice. The system analyzes the first digital image and defines regions of non-intact glands. Intact gland regions are then determined, and regions of stroma are identified. The system defines influence zones between non-intact regions and stroma regions. Using information from the second image, macrophages in the tissue corresponding to the influence zones are identified and counted. Based at least in part on this count, the system determines a score. The score is indicative of whether the patient will experience PSA recurrence.


Find Patent Forward Citations

Loading…